SLE and cardiovascular disease Archives

Abstract Number: 764 • ACR/ARHP Annual Meeting 2018
Cardiovascular Disease in SLE at One Center between 1981 and 2016. a Population-Based Study Highlighting the Importance of Disease Duration and Age at Diagnosis
Ola Nived¹, Ragnar F Ingvarsson¹, Anna Jöud², Petrus Linge¹, Helena Tydén¹, Anders A. Bengtsson¹ and Andreas Jönsen¹, ¹Rheumatology, Lund University, Department of Clinical Sciences, Lund, Sweden, ²Division of Occupational and Environmental Medicine, Lund University, Department of Laboratory Medicine, Lund, Sweden
Background/Purpose: Active inflammatory processes characterize early SLE disease, while later morbidity to a considerable extent consists of consequences of organ damage, particularly cardiovascular disease (CVD).…
Abstract Number: 2044 • ACR/ARHP Annual Meeting 2017
Secondary Prevention of Cardiovascular Disease Is Incomplete in a Systemic Lupus Erythematosus Population-Based Cohort
Suzana John¹, Cristina Drenkard², Gaobin Bao² and S. Sam Lim², ¹Rheumatology, Emory University, Atlanta, GA, ²Division of Rheumatology, Emory University School of Medicine, Atlanta, GA
Background/Purpose: Cardiovascular disease (CVD) is a common cause of morbidity and mortality in systemic lupus erythematosus (SLE). We know that a combination of traditional cardiovascular…
Abstract Number: 690 • ACR/ARHP Annual Meeting 2017
SSA Antibodies Are Associated with Valvular Abnormalities in SLE Patients without Clinical Cardiovascular Disease
Elizabeth George¹, Thania Perez², Anca Askanase³ and Laura Geraldino-Pardilla⁴, ¹Rheumatology, Columbia University College of Physicians and Surgeons, New york, NY, ²Columbia University College of Physicians & Surgeons, New York, NY, ³Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, ⁴Columbia University, New york, NY
Background/Purpose: Cardiovascular involvement including pericardium, conduction system, coronary arteries and valvular abnormalities are frequent manifestations of SLE. It is estimated to occur in more than…
Abstract Number: 985 • ACR/ARHP Annual Meeting 2017
Heart Failure Hospitalizations Among SLE and Diabetes Mellitus Patients Compared to the General U.S. Medicaid Population
Sarah Chen¹, Medha Barbhaiya², Michael A. Fischer³, Hongshu Guan⁴, Candace H. Feldman⁵, Brendan M. Everett⁶ and Karen H. Costenbader⁷, ¹Brigham and Women's Hospital, Boston, MA, ²Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ³Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁴Rheumatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁵Rheumatology, Brigham & Women's Hospital, Boston, MA, ⁶Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁷Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Cardiovascular disease (CVD) risk is increased in SLE patients, compared to the general population and age- and sex-matched diabetes mellitus (DM) patients. Heart failure…
Abstract Number: 1632 • ACR/ARHP Annual Meeting 2017
SLE Characteristics Associated with Modified Framingham Risk Score in Patients without Clinical Cardiovascular Disease
Elizabeth George¹, Thania Perez², Nelson Perez³, Anca Askanase⁴ and Laura Geraldino-Pardilla⁵, ¹Rheumatology, Columbia University College of Physicians and Surgeons, New york, NY, ²Columbia University College of Physicians & Surgeons, New York, NY, ³Hospital Regional Universitario Jose Maria Cabral y Baez, Santiago, Dominican Republic, ⁴Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, ⁵Columbia University, New york, NY
Background/Purpose: Cardiovascular disease (CVD) is a leading cause of mortality in SLE and identifying those at risk remains challenging. While in the general population the…
Abstract Number: 1303 • ACR/ARHP Annual Meeting 2016
Extended T2-Times in Cardiovascular Magnetic Resonance (CMR) in Patients with Systemic Lupus Erythematosus (SLE) and Persisted Dyspnoea: Is SLE-Associated Myocarditis an Underestimated Problem?
Dr. Philipp Sewerin¹, Vera Lachmann², Mareike Gastl², Patrick Behm³, PD Dr. Rebecca Fischer-Betz⁴, Prof. Dr. Benedikt Ostendorf¹, Dr. Gamal Chehab⁵, Prof. Dr. Matthias Schneider¹, Prof. Dr. Malte Kelm² and Dr. Florian Bönner², ¹Department of Rheumatology & Hiller Research Unit, Heinrich-Heine University, Düsseldorf, Germany, ²Department of Internal Medicine, Division of Cardiology, Pulmology and Vascular Medicine and Molecular Cardiology, Heinrich-Heine University, Düsseldorf, Germany, ³Heinrich-Heine University, Düsseldorf, Germany, ⁴Department of Rheumatology & Hiller Research Unit, Heinrich-Heine-University, Duesseldorf, Germany, ⁵Department of Rheumatology & Hiller Research Unit, Heinrich-Heine University, 40225 Duesseldorf, Germany
Background/Purpose: To investigate the value of cardiovascular magnetic resonance (CMR) and T2-mapping in patients with systemic lupus erythematosus (SLE) and persistent dyspnoea without sings for…
Abstract Number: 1068 • ACR/ARHP Annual Meeting 2015
Assessment of 10-Year Risk of Myocardial Infarction or Stroke in SLE
Michelle Petri¹ and Laurence S Magder², ¹Johns Hopkins University School of Medicine, Baltimore, MD, ²University of Maryland School of Medicine, Baltimore, MD
B Background/Purpose: In 2013 the American College of Cardiology (ACC) and the American Heart Association (AHA) developed a new formula to estimate the 10-year risk…
Abstract Number: 1794 • ACR/ARHP Annual Meeting 2015
Unexplained Decline in Rates of Cardiovascular Events in a Large Cohort of SLE Patients
Michelle Petri¹ and Laurence S Magder², ¹Johns Hopkins University School of Medicine, Baltimore, MD, ²University of Maryland School of Medicine, Baltimore, MD
Background/Purpose: We have observed a decline in rates of cardiovascular events in systemic lupus erythamatosus (SLE) pateints in our clinic. In this work presented below,…
Abstract Number: 2790 • ACR/ARHP Annual Meeting 2014
CMR with Quantitative T2 Mapping in Patients with Active SLE
Stacy P. Ardoin¹, Wael N. Jarjour², Subha V. Raman², Amanda Kibler² and Tam Tran², ¹Pediatric & Adult Rheumatology, Ohio State University College of Medicine, Columbus, OH, ²Ohio State University, Columbus, OH
Background/Purpose: Cardiovascular (CV) disease is an important cause of morbidity in systemic lupus erythematosus (SLE) . Myocarditis is considered an uncommon complication of SLE…
Abstract Number: 705 • ACR/ARHP Annual Meeting 2014
Lupus Chest Pain in the Emergency Department: a Common Diagnostic Dilemma
Masoom Modi¹, Mariko L. Ishimori¹, Daniel J. Wallace² and Michael Weisman¹, ¹Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, ²Rheumatology, Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA
Background/Purpose: Chest pain (CP) is a common symptom reported by SLE patients often leading to presentation to Emergency Departments (ED). The origin of CP…

Abstracts tagged "SLE and cardiovascular disease"